(NASDAQ: TELA) Tela Bio's forecast annual revenue growth rate of 10.3% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.75%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.13%.
Tela Bio's revenue in 2026 is $80,814,000.On average, 7 Wall Street analysts forecast TELA's revenue for 2026 to be $3,960,998,130, with the lowest TELA revenue forecast at $3,772,622,188, and the highest TELA revenue forecast at $4,098,788,328. On average, 7 Wall Street analysts forecast TELA's revenue for 2027 to be $4,371,100,794, with the lowest TELA revenue forecast at $4,176,502,357, and the highest TELA revenue forecast at $4,541,525,512.
In 2028, TELA is forecast to generate $4,878,166,930 in revenue, with the lowest revenue forecast at $4,640,458,694 and the highest revenue forecast at $5,091,253,785.